SUSMED,Inc. Income Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	453	342	530	316	115	34
Revenue Growth (YoY)	33.23%	-35.47%	67.72%	174.78%	238.24%	-
Cost of Revenue	10	12	8	11	9	1
Gross Profit	443	330	522	305	106	33
Selling, General & Admin	459	452	394	309	190	107
Research & Development	268	243	176	226	249	86
Operating Expenses	727	695	570	535	439	193
Operating Income	-284	-365	-48	-230	-333	-160
Other Non Operating Income (Expenses)	5	8	4	12	60	71
EBT Excluding Unusual Items	-279	-357	-44	-218	-273	-89
Gain (Loss) on Sale of Assets	-	-	-	-	-4	-7
Asset Writedown	-4	-2	-5	-15	-	-
Other Unusual Items	-	3	-	-	-	-
Pretax Income	-283	-356	-49	-233	-277	-96
Income Tax Expense	1	1	1	-	-	-
Net Income	-284	-357	-50	-233	-277	-96
Net Income to Common	-284	-357	-50	-233	-277	-96
Shares Outstanding (Basic)	17	17	16	15	13	12
Shares Outstanding (Diluted)	17	17	16	15	13	12
Shares Change (YoY)	0.77%	1.77%	11.71%	14.76%	11.19%	-
EPS (Basic)	-16.93	-21.39	-3.05	-15.87	-21.65	-8.34
EPS (Diluted)	-16.93	-21.39	-3.05	-15.87	-21.65	-8.34
Free Cash Flow	-	-233	94	-177	-	-
Free Cash Flow Per Share	-	-13.96	5.73	-12.05	-	-
Gross Margin	97.79%	96.49%	98.49%	96.52%	92.17%	97.06%
Operating Margin	-62.69%	-106.73%	-9.06%	-72.78%	-289.56%	-470.59%
Profit Margin	-62.69%	-104.39%	-9.43%	-73.73%	-240.87%	-282.35%
Free Cash Flow Margin	-	-68.13%	17.74%	-56.01%	-	-
EBITDA	-279	-360	-43	-228	-	-
EBITDA Margin	-61.59%	-105.26%	-8.11%	-72.15%	-	-
D&A For EBITDA	5	5	5	2	-	-
EBIT	-284	-365	-48	-230	-333	-160
EBIT Margin	-62.69%	-106.73%	-9.06%	-72.78%	-289.56%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.